( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
2120.4
1633.1
1408.5
2007.2
Total Expenditure
2203.8
1806.1
1488.9
2011.6
PBIDT (Excl OI)
-83.40
-173
-80.40
-4.39
Other Income
34.5
18.3
6.4
38.5
Operating Profit
-48.90
-154.7
-73.99
34.10
Exceptional Items
-24.9
205.6
NA
22.3
PBDT
-115.8
-1.40
-108.7
26.90
Depreciation
15.3
16.4
16.2
15.1
Profit Before Tax
-131.1
-17.80
-124.9
11.80
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-131.1
-17.80
-124.9
11.80
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-131.1
-17.80
-124.9
11.80
Equity Capital
369.6
280.6
231.1
231.1
Calculated EPS
-0.35
-0.06
-0.54
0.05
Calculated EPS (Annualised)
-1.41
-0.25
-2.16
0.20
No of Public Share Holdings
219740595
130790695
107709981
107709981
% of Public Share Holdings
59.49
46.64
46.64
46.64
PBIDTM% (Excl OI)
-3.93
-10.59
-5.70
-0.21
PBIDTM%
-2.30
-9.47
-5.25
1.69
PBDTM%
-5.46
-0.08
-7.71
1.34